Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta-2-syntrophin (SNTB2) is a 59 kDa peripheral membrane-associated adapter protein encoded by the SNTB2 gene and is a member of the syntrophin family, which includes several structurally related proteins. Syntrophin beta 2 is characterized by multiple protein-protein interaction domains, notably two pleckstrin homology (PH) domains, a PDZ domain, and a C-terminal syntrophin unique (SU) domain. It is predominantly expressed in skeletal and cardiac muscle, where it serves as a scaffold protein within the dystrophin-associated protein complex (DAPC), organizing membrane protein localization, linking receptors to the actin cytoskeleton, and assisting in the functional architecture of muscle cell membranes. SNTB2 is involved in processes such as regulation of signaling complexes and maintenance of membrane structural integrity. Mutations or dysfunction of the dystrophin-associated protein complex, including beta-2-syntrophin, are implicated in neuromuscular diseases like muscular dystrophy. Syntrophin beta 2 is not a direct drug target or therapeutic receptor, but its roles in protein trafficking, cytoskeletal organization, and membrane stability are crucial for cell function in muscle and possibly other tissues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-2-syntrophin (SNTB2).